Nacia Pupo Taylor

Led a global team across three continents advancing Johnson & Johnson's interests in public health, pandemic preparedness, healthcare financing and sustainability, and immunization policy, while serving on leadership teams for both J&J's Worldwide Government Affairs and J&J's Global Health Equity organizations. Represented the company in major global health forums and trade organizations, serving on multiple advisory boards and orchestrating executive engagement in high-level government interactions.

Stood up and led J&J's corporate vaccine policy team during the pandemic, supporting COVID-19 response across critical areas including vaccine access, supply chain, intellectual property, and novel global procurement models. Developed and implemented government affairs strategies to elevate J&J's priority diseases in the global agenda. Elevated corporate reputation through high-level engagements and partnerships with key stakeholders, including U.S., U.K., and German governments, G7 and G20 forums, WHO, WTO, trade associations, and civil society organizations.

Led external engagement on complex policy issues affecting access to Janssen and J&J Medical Devices in Latin America, including Brazil's private healthcare insurance reform and intellectual property protections in regional pooled procurement mechanisms. Established a policy team integrated within both pharmaceutical and medical device businesses, and enhanced industry advocacy capacity and J&J's leadership in FIFARMA. Designed and implemented a new policy function supporting J&J's Global Public Health efforts by integrating teams, defining clear priority areas for collaboration, and developing a new operating model.

Led comprehensive policy intelligence, analysis, and strategic direction on diverse topics affecting market access for J&Js technologies in Latin America, including healthcare system structure and financing, health technology assessment, value-based hospital payment models, and regulatory, trade, and intellectual property policies. Spearheaded external health policy engagement as the primary representative with multilateral, international, and multi-country stakeholders across the region. Developed evidence-based, patient-focused policy positions and crafted strategic supporting materials to address issues affecting the company's Medical Devices, Pharmaceuticals, and Consumer sectors throughout Latin America.

Led multi-country team responsible for all marketing functions of the Diabetes Care Franchise in Latin America: strategic planning, product portfolio and regulatory strategy, professional and patient communication strategy as well as sales and operations planning and customer support centers.

Full profit and loss (P&L) responsibility for the business in the 200-million inhabitant Brazilian market. Led turn around of the business to reach sustainable sales growth and regain profitability via a complete re-structuring of the business.

Full P&L responsibility for both businesses simultaneously: ADVANCED STERILIZATION PRODUCTS (ASP): Achieved record-breaking sales and placement of equipment in hospital accounts by implementing changes in the equipment financing, distribution strategy, clinical assistance and sales structure. ETHICON WOMEN'S HEALTH & UROLOGY: Led strategic planning process for the business as part of a larger “Emerging Markets” initiative. Generated double-digit sales growth by implementing a heightened focus on professional education, account planning, and field execution.

Drove marketing strategy and execution for the large bariatric surgery segment in Brazil, including management of relationships with key opinion leaders, leading medical teaching institutions, and professional and patient associations. Advanced professional education, increased procedure penetration, and expanded market share.

Managed overall franchise marketing activities for both businesses across Latin America. Led portfolio strategy and implementation, launching products such as TVT-Obturator, TVT-S, Mammotome EX and Mammotome MR and associated marketing and professional education activities.

Max Factor Cosmetics: Marketing operations for the US, Canada, and Puerto Rico. Pantene, Pert Plus, Head and Shoulders: Marketing, consumer research, advertising and public relations.